# Sandrine Faivre

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sandrine-faivre/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,082 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 69 |
| i10-index | 191 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5002864173 |
| ORCID iD | https://orcid.org/0000-0002-1590-485X |
| Works | 505 |

## Researcher papers

- [Targeting the TGFβ pathway for cancer therapy](https://scholariq.org/papers/targeting-the-tgf-pathway-for-cancer-therapy/)
- [MEK in cancer and cancer therapy](https://scholariq.org/papers/mek-in-cancer-and-cancer-therapy/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.